Gregory Evan Kraut Insider Profile
4 Followers
Gregory Evan Kraut, former Director at Sonnet BioTherapeutics Holdings, holds 30.52K shares in Sonnet BioTherapeutics Holdings (Ticker: SONN).
Gregory Evan Kraut's Trading History
You May Also Like
Gregory Evan Kraut insider profile FAQ
What is the percentage of profitable transactions made by Gregory Evan Kraut?
The percentage of profitable transactions made by Gregory Evan Kraut is 43%.
What is the average return per transaction made by Gregory Evan Kraut?
The average return per transaction made by Gregory Evan Kraut is -23.20%.
What stocks does Gregory Evan Kraut hold?
Gregory Evan Kraut holds: SONN stocks.
What was Gregory Evan Kraut’s latest transaction?
Gregory Evan Kraut’s latest transaction was an Uninformative Buy of $16.55K.
What was Gregory Evan Kraut's most profitable transaction?
Gregory Evan Kraut’s most profitable transaction was an Informative Buy of SONN stock on June 6, 2017. The return on the trade was 20.80%.
What is Gregory Evan Kraut's role in Sonnet BioTherapeutics Holdings?
Gregory Evan Kraut's role in Sonnet BioTherapeutics Holdings is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
